Invuity Inc. Showcased PhotonBlade at Premier Inc.’s Annual Breakthroughs Conference
July 12 2017 - 4:01PM
Invuity’s (Nasdaq:IVTY) PhotonBlade, precision illuminator with
next-generation enhanced energy, is one of the medical innovations
that was showcased in front of thousands of healthcare providers at
Premier Inc.’s 2017 Breakthroughs Conference and Exhibition on June
27.
PhotonBlade was debuted during the conference’s annual
Innovation Celebration. The event recognizes advances in healthcare
while highlighting industry suppliers committed to innovation and
improving patient outcomes.
“Invuity shares Premier’s commitment to providing valuable
products to our alliance members that are safe, high-quality and
cost-effective,” said Durral R. Gilbert, president of supply chain
services, Premier. “We believe these innovations can benefit
providers as they work to transform healthcare.”
Clinicians and other health system members of Premier selected
PhotonBlade to be showcased at the Innovation Celebration due to
its uniqueness, ability to have an impact on unmet clinical needs
and potential to improve patient care.
For surgeons who perform minimal access surgery, PhotonBlade
provides direct, thermally cool illumination at the precise point
of surgical treatment. Further, PhotonBlade’s novel energy platform
consists of a proprietary coated blade for precise cutting and
coagulation of tissue, with minimal collateral effect. This
sophisticated illumination technology further allows for unique use
in a fluid filled environment and does not require a proprietary
generator, thereby leveraging widely available operating room
equipment and avoiding an institutional capital investment.
PhotonBlade provides exceptional visualization within the surgical
cavity, for precision and safety.
“We are honored to have received this recognition from Premier,”
stated President and CEO of Invuity Philip Sawyer. “It demonstrates
the consistent goals of both Invuity and Premier in constantly
striving to provide the best possible care for patients. We will
continue to develop innovative technology for healthcare providers
that positively impacts patient lives.”
Any supplier, regardless of whether the company is contracted
with Premier, can be considered for participation in the Innovation
Celebration. Premier contracts with more than 1,200 suppliers.
For more detailed information, including a video of PhotonBlade
visit:
http://breakthroughs.premierinc.com/innovation-celebration-2017/
About Premier Inc.Premier Inc. is a leading
healthcare improvement company, uniting an alliance of
approximately 3,750 U.S. hospitals and more than 130,000 other
provider organizations. With integrated data and analytics,
collaboratives, supply chain solutions, and advisory and other
services, Premier enables better care and outcomes at a lower cost.
Please visit Premier’s news and investor sites on
www.premierinc.com.
About Invuity® Inc.Invuity, Inc. is a
leading medical technology company focused on developing and
marketing advanced surgical devices to improve the ability of
physicians to perform minimal access surgery through smaller and
hidden incisions. The company's proprietary Intelligent Photonics™
technology delivers enhanced visualization which facilitates
surgical precision, efficiency and safety. In addition, the company
utilizes comprehensive strategic marketing programs to create
stronger institutional partnerships. Clinical applications include
women’s health, encompassing breast cancer and breast
reconstruction surgery, gynecology and thyroid surgery. Additional
applications include procedures for electrophysiology, spine,
orthopedic, cardiothoracic, and general
surgery. Invuity is headquartered in San Francisco,
CA. For more information, visit invuity.com.
Forward-Looking Statements
This announcement contains forward-looking statements that
involve risks and uncertainties, including statements regarding
expectations for PhotonBlade, future product development and our
commercial strategies. Actual results could differ materially from
those projected in the forward-looking statements as a result of
certain risk factors, including, but not limited to: fluctuations
in demand or failure to gain market acceptance for the Company's
devices; the Company's ability to demonstrate to and gain approval
from hospitals to use the Company's devices; the highly competitive
business environment for surgical medical devices; the Company's
ability to sell its devices at prices that support its current
business strategies; difficulty forecasting future financial
performance; protection of the Company's intellectual property; and
compliance with necessary regulatory clearances or approvals. The
Company undertakes no obligation to update the forward-looking
information in this release. More information about potential
factors that could affect the Company's business and financial
results is included in its filings with the Securities and Exchange
Commission, including, without limitation, under the captions:
"Management's Discussion and Analysis of Financial Condition and
Results of Operations," and "Risk Factors," which are on file with
the Securities and Exchange Commission.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024